Shares of Boston Scientific Corp. (BSX) increased around 3 percent in the extended trading on Monday after the company announced that it has received approval from the U.S. Food and Drug Administration for the Vercise Deep Brain …
Another rally sits ready to move stocks higher on Tuesday as the S&P 500 Index is starting to make a rush at making …
The stock had risen about 13 percent in January ... adding the company expects to have about $500 million from its cash flow to spend in 2018. Boston Scientific has focused on making smaller, bolt-on acquisitions to bolster its businesses.
Boston Scientific Corporation BSX is scheduled to report second-quarter 2017 results before the opening bell on Jul 27. Last quarter, the company’s earnings missed the Zacks Consensus Estimate by 3.3%. However, it posted an average …
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Halliburton (HAL), Boston Scientific (BSX), and Anheuser-Busch …